Description:6,8-Dimethoxymoxifloxacin is a synthetic fluoroquinolone antibiotic, structurally related to moxifloxacin, which is used to treat various bacterial infections. This compound features two methoxy groups at the 6 and 8 positions of the quinolone ring, which can influence its pharmacological properties, including its antibacterial activity and bioavailability. Like other fluoroquinolones, it works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication and repair. The presence of the methoxy groups may enhance its lipophilicity, potentially improving tissue penetration. 6,8-Dimethoxymoxifloxacin is expected to exhibit a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Its safety profile and side effects would be similar to those of other fluoroquinolones, which can include gastrointestinal disturbances, central nervous system effects, and potential tendon damage. As with any antibiotic, appropriate susceptibility testing is essential to ensure its effectiveness against specific pathogens. Further research may be needed to fully elucidate its pharmacokinetics and therapeutic potential.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
